Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer’s Disease

Documenti analoghi

• Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer’s Disease
  di: Reddy, P. Hemachandra, et al.
  Pubblicazione: (2018)
• Protective effects of BACE1 inhibitory ligand molecules against amyloid beta-induced synaptic and mitochondrial toxicities in Alzheimer’s disease
  di: Pradeepkiran, Jangampalli Adi, et al.
  Pubblicazione: (2020)
• Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease
  di: Reddy, P Hemachandra, et al.
  Pubblicazione: (2018)
• Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease
  di: Yin, Xiangling, et al.
  Pubblicazione: (2016)
• Amyloid-β and Mitochondria in Aging and Alzheimer’s Disease: Implications for Synaptic Damage and Cognitive Decline
  di: Reddy, P. Hemachandra, et al.
  Pubblicazione: (2010)